Trials / Sponsors / FengYan Jin
FengYan Jin
Academic / Other · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Risk-adapted Therapeutic Strategy in +1q NDMM Multiple Myeloma | — | 2025-09-15 |
| Recruiting | Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma Multiple Myeloma, First Relapse | — | 2023-06-15 |
| Recruiting | Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Primary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma Treatment | N/A | 2022-12-02 |
| Recruiting | A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persist Multiple Myeloma, Minimal Residual Disease | — | 2022-01-10 |
| Recruiting | Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM Multiple Myeloma, Frailty | — | 2021-09-08 |